| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.4M | -8.6% |
| Cost of Revenue | $89.8M | -41.4% |
| R&D Expense | $18.7M | +1.3% |
| SG&A Expense | $53.6M | -11.5% |
| Operating Income | -$152.9M | +30.9% |
| Pre-tax Income | -$229.5M | +0.1% |
| Income Tax | $31K | -39.2% |
| Net Income | -$229.5M | +0.1% |
| EPS (Basic) | -$1.81 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.5M | +306.8% |
| Accounts Receivable | $3.4M | +103.3% |
| Inventory | $17.1M | -26.6% |
| Current Assets | $122.3M | +121.8% |
| Total Assets | $186.5M | +74.6% |
| Current Liabilities | $60.9M | +0.5% |
| Long-term Debt | $203.9M | +15.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.0M | +26.3% |
| Capital Expenditures | $29.3M | +46.1% |
| Investing Cash Flow | -$29.5M | -71.6% |
| Financing Cash Flow | $227.9M | +63.3% |
| Free Cash Flow | -$174.3M | +19.6% |
| +50.8% |
| EPS (Diluted) | -$1.81 | +50.8% |
| Total Liabilities |
| $297.3M |
| +24.1% |
| Stockholders' Equity | -$110.8M | +16.5% |